Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 125, Issue 1, Pages 65-74Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI73944
Keywords
-
Categories
Funding
- Wellcome Trust Principal Research Fellowship
- Wellcome Trust/MRC Strategic Grant on Neurodegeneration
- Sims Scholarship from the FEE Fund
- JB Fund
- NIHR Biomedical Research Centre at Addenbrooke's Hospital
- Tau Consortium
- Alzheimer's Research UK
Ask authors/readers for more resources
Most neurodegenerative diseases that afflict humans are associated with the intracytoplasmic deposition of aggregate-prone proteins in neurons. Autophagy is a powerful process for removing such proteins. In this Review, we consider how certain neurodegenerative diseases may be associated with impaired autophagy and how this may affect pathology. We also discuss how autophagy induction may be a plausible therapeutic strategy for some conditions and review studies in various models that support this hypothesis. Finally, we briefly describe some of the signaling pathways that may be amenable to therapeutic targeting for these goals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available